Insulin caps lowered costs but didn't improve access, study finds

State caps on insulin costs lowered privately insured patients' out-of-pocket spending, but they didn't appear to increase insulin use, according to a new Annals of Internal Medicine study.

Why it matters: The research suggests increasingly popular insulin caps alone aren't enough to improve insulin uptake among patients with diabetes in commercial insurance.